The Journal of Urology
Volume 182, Issue 3 , Pages 832-833 , September 2009

Radical Nephrectomy in the Setting of Metastatic Renal Cell Cancer: Proceed Judiciously

  • Monish Aron

      Affiliations

    • Section of Laparoscopic and Robotic Surgery, Glickman Urological and Kidney Institute, Cleveland Clinic, Cleveland, Ohio
    • ,
  • Inderbir S. Gill

      Affiliations

    • Department of Urology, University of Southern California, Los Angeles, California

References 

  1. Rendon RA. New surgical horizons: the role of cytoreductive nephrectomy for metastatic kidney cancer. Can Urol Assoc J. 2007;1(suppl.):S62
  2. Flanigan RC, Mickisch G, Sylvester R, et al. Cytoreductive nephrectomy in patients with metastatic renal cancer: a combined analysis. J Urol. 2004;171:1071
  3. Fallick ML, McDermott DF, LaRock D, et al. Nephrectomy prior to interleukin-2 therapy for patients with metastatic renal cell carcinoma. J Urol. 1997;158:1691
  4. Kassouf W, Sanchez-Ortiz R, Tamboli P, et al. Cytoreductive nephrectomy for T4NxM1 renal cell carcinoma: the M.D. Anderson Cancer Center experience. Urology. 2007;69:835
  5. Bromwich E, Hendry D, Aitchison M. Cytoreductive nephrectomy: is it a realistic option in patients with renal cancer?. BJU Int. 2002;89:523
  6. Krambeck AE, Leibovich BC, Lohse CM, et al. The role of nephron sparing surgery for metastatic (pM1) renal cell carcinoma. J Urol. 2006;176:1990
  7. Hutterer GC, Patard JJ, Colombel M, et al. Cytoreductive nephron-sparing surgery does not appear to undermine disease-specific survival in patients with metastatic renal cell carcinoma. Cancer. 2007;110:2428
  8. Thomas AA, Rini BI, Lane BR, et al. Response of the primary tumor to neoadjuvant sunitinib in patients with advanced renal cell carcinoma. J Urol. 2009;181:518

PII: S0022-5347(09)01611-5

doi: 10.1016/j.juro.2009.06.076

The Journal of Urology
Volume 182, Issue 3 , Pages 832-833 , September 2009

Article Tools